Moleculin Biotech
| Region | Nordamerika |
| ISIN | US60855D1019 |
| Sektor | Biotechnologie |
| Website | http://www.moleculin.com/ |
Moleculin Biotech is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center, the world’s largest cancer research facility headquartered within the world’s largest medical center.
| Titel | Datum |
|---|---|
| Bursa, RHB, Hong Leong Bank, Axiata, MISC, IOI Properties, TM, GenP, Kerjaya Prospek, Sime Darby Property, 7-Eleven Malaysia, AAX, Pestec... | vor 7 Tagen |
| MISC's 1Q net profit falls 7%, declares eight sen dividend | vor 7 Tagen |
| MISC could potentially pay out higher dividends starting 2025 - Maybank | vor ungefähr 2 Monaten |
| MISC tied to $312M HD Hyundai deal for 'world's largest' ethane carriers | vor ungefähr 3 Monaten |
| MISC secures long-term contracts for two ethane carriers from Thailand's PTT | vor ungefähr 3 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Minori Solutions (1 Artikel) | |
| Microsoft (1 Artikel) | |
| Moovly Media (1 Artikel) | |
| MorphoSys (1 Artikel) | |
| Alle anzeigen | |